LIVN News - Candlesense

LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September

LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that Vladimir Makatsaria, Chief Executive Officer, and A...

Conference

about 10 hours ago

LivaNova Launches Essenz Perfusion System in China

LONDON--(BUSINESS WIRE)---- $LIVN #cardiacsurgery--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it initiated the commercial launch of the Essenz™ Perfus...

What timeline and regulatory milestones should we expect for broader adoption and possible reimbursement approvals that could affect the long‑term valuation of LIVN? What is the competitive landscape for heart‑lung machines in China and how does the Essenz system compare on price, technology, and market share potential? How will the commercial launch of the Essenz Perfusion System in China impact LivaNova's near‑term revenue and earnings estimates?

Product launch

4 days ago

LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC reported results for the second quarter ended June 30, 2025, and raised full-year 2025 guidance.

How should the updated guidance be weighted against macro‑economic factors affecting the medical device industry? Does the company provide any new guidance on product pipelines or market expansions that could affect future earnings? What potential risks or headwinds could derail the 2025 guidance assumptions?

Earnings

17 days ago